You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江蘇吳中(600200.SH):全資子公司簽署投資及技術合作協議
格隆匯 10-25 20:02

格隆匯10月25日丨江蘇吳中(600200.SH)公佈,公司全資子公司江蘇吳中美學生物科技有限公司(以下簡稱“吳中美學”)與南京東萬生物技術有限公司(以下簡稱“南京東萬”或“目標公司”)簽署了《投資及技術合作協議》。

按照目標公司投後估值人民幣5億元(對應每1元註冊資本價格為人民幣17.6386元),吳中美學以人民幣1000萬元認購目標公司新增註冊資本人民幣56.6939萬元。同時,吳中美學與目標公司達成技術合作,吳中美學取得目標公司重組人膠原蛋白原料在合作領域內的獨家經銷權與獨家開發權,該膠原蛋白通過CHO細胞體系表達,並由中國食品藥品檢定研究院出具的檢測報吿認為其具有膠原蛋白三螺旋結構,同時委託目標公司基於該重組人膠原蛋白原料開發相關III類醫療器械產品,合作金額為人民幣2000萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account